| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Revenue | $86.3M | +8.3% |
| Cost of Revenue | $58.2M | -2.1% |
| Gross Profit | $28.1M | +38.8% |
| R&D Expense | $945K | -23.1% |
| SG&A Expense | $18.7M | +3.8% |
| Operating Income | -$1.6M | +84.5% |
| Pre-tax Income | -$3.1M | +73.6% |
| Income Tax | $60K | +42.9% |
| Net Income | -$3.2M |
| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.3M | -45.3% |
| Accounts Receivable | $16.3M | +27.2% |
| Inventory | $10.3M | -9.6% |
| Current Assets | $37.7M | +6.2% |
| Total Assets | $51.6M | -1.6% |
| Current Liabilities | $26.7M | -0.6% |
| Long-term Debt | $6.0M | -42.2% |
| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.1M | -280.1% |
| Capital Expenditures | $83K | -16.2% |
| Investing Cash Flow | -$86K | -167.2% |
| Financing Cash Flow | -$1.5M | -1813.3% |
| Free Cash Flow | -$1.2M | -332.4% |
| +73.2% |
| EPS (Basic) | -$0.89 | -147.2% |
| EPS (Diluted) | -$0.89 | -147.2% |
| Total Liabilities |
| $35.0M |
| -13.8% |
| Stockholders' Equity | $16.6M | +39.9% |